Grazyna Pulka Specjalistyczny Osrodek ALL-MED
Krakow 31-024
0 studies enrolling now · 8 studies all time
What they study most
Asthma, Cardiovascular Disease, Chronic Plaque Psoriasis, Moderate to Severe Plaque Psoriasis, Obesity, Overweight, Plaque Type Psoriasis, Psoriasis, Rheumatoid Arthritis, Type 2 Diabetes
Studies at this site
- REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels — Running, not enrolling
- A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma — Completed
- A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication — Completed
- A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4) — Completed
- Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed
- MSB11022 in Moderate to Severe Chronic Plaque Psoriasis — Completed
- Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis — Completed
- Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis — Completed